SITC 2024 Supporters

SITC 2024 Supporters

SITC gratefully acknowledges the following supporters of the society's 39th Annual Meeting & Pre-Conference Programs.

39th Annual Meeting

Platinum

Bristol Myers Squibb

Silver

 Sanofi US

Bronze

Merck Sharp & Dohme, Corp., a subsidiary of Merck & Co., Inc.

Novartis Pharmaceuticals Corporation

Copper

Bayer HealthCare Pharmaceuticals Inc. (Young Investigator Travel Awards)

Genentech USA, Inc. (Young Investigator Travel Awards for Underrepresented Groups)


Primer on Tumor Immunology and Cancer ImmunotherapyTM

Silver

Merck Sharp & Dohme, Corp., a subsidiary of Merck & Co., Inc.

Bronze

Novartis Pharmaceuticals Corporation

Copper

Genmab US, Inc.


Immune Engineering Workshop

Gold

Bristol Myers Squibb

Bronze

Kite Pharma, Inc.

Copper

Pfizer, Inc.

Tumor Infiltrating Lymphocytes (TIL) Program

Bronze

KSQ Therapeutics, Inc. (Luncheon)

Obsidian Therapeutics, Inc. (Luncheon)

Copper

Achilles Therapeutics

CTMC+

Beyond Checkpoint Inhibitors: New Immuno-oncology Modalities and Approaches (SITC's Industry Program)

Grant Writing Workshop

 

Supporters as of July 23, 2024